Learn More
Medchemexpress LLC Mal-PEG4-VC-PAB-DMEA-PNU-159682 | 2259318-52-8 | 96.2% | 1559.62 | C74H98N10O27 | 1 MG

Supplier: Medchemexpress LLC HY1266871MG
Mal-PEG4-VC-PAB-DMEA-PNU-159682 is a drug-linker conjugate used in antibody-drug conjugate (ADC) research. It combines a cleavable maleimide-PEG4-valine-citrulline-PAB-DMEA linker with a potent cytotoxic payload to enable studies of conjugation chemistry, linker stability, and payload release in vitro.
- Cleavable valine-citrulline peptide linker enabling enzymatic release.
- Maleimide functional group for thiol conjugation to antibodies.
- PEG4 spacer to improve solubility and spacing between antibody and payload.
- Conjugated to a potent cytotoxin for payload delivery studies.
- Supplied in small pack sizes suitable for early stage research.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.